Ferra Joseph J Jr 4
4 · Elevation Oncology, Inc. · Filed May 19, 2025
Insider Transaction Report
Form 4
Ferra Joseph J Jr
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Exercise/Conversion
Restricted Stock Unit
2025-05-15−6,250→ 68,750 total→ Common Stock (6,250 underlying) - Exercise/Conversion
Common Stock
2025-05-15+6,250→ 139,455 total - Tax Payment
Common Stock
2025-05-15$0.30/sh−2,303$690→ 137,152 total
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
- [F2]25% of the RSUs vested on February 15, 2025, and the remainder will vest as to 1/16 of the total RSUs quarterly until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.
- [F3]The RSUs do not expire; they either vest or are canceled prior to the vesting date.